Company profile for iStar Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

STAR Medical has exclusive rights to the STAR® biomaterial from the University of Washington in Seattle (USA) for ophthalmic use. The porous material exhibits outstanding anti-fibrotic and anti-inflammatory properties providing the foundation for the development of MINIjectTM, designed to be a best-in-class micro-invasive glaucoma surgery (MIGS) device. MIGS is the most promising and fastest-growing therapeutic option for the...
STAR Medical has exclusive rights to the STAR® biomaterial from the University of Washington in Seattle (USA) for ophthalmic use. The porous material exhibits outstanding anti-fibrotic and anti-inflammatory properties providing the foundation for the development of MINIjectTM, designed to be a best-in-class micro-invasive glaucoma surgery (MIGS) device. MIGS is the most promising and fastest-growing therapeutic option for the treatment of glaucoma. The fast-growing glaucoma surgical device market is expected to reach $1.84 bn worldwide by 2025.The company is backed by specialised institutional and private investors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Avenue Sabin, 6 1300 Wavre
Telephone
Telephone
+32 10 77 16 54
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/24/3067115/0/en/iSTAR-Medical-s-MINIject-demonstrates-significant-sustained-5-year-efficacy-in-treating-glaucoma-in-STAR-GLOBAL-trial.html

GLOBENEWSWIRE
24 Apr 2025

https://www.globenewswire.com/news-release/2024/09/04/2940361/0/en/iSTAR-Medical-continues-to-strengthen-US-presence-with-appointment-of-Chief-Medical-Officer-and-Vice-President-of-Clinical-Affairs.html

GLOBENEWSWIRE
04 Sep 2024

https://www.globenewswire.com//news-release/2024/01/10/2806841/0/en/iSTAR-Medical-Expands-International-Commercial-Rollout-of-MINIject-with-Successful-First-Implants-Completed-in-Australia.html

GLOBENEWSWIRE
10 Jan 2024

https://www.globenewswire.com/news-release/2023/12/22/2800541/0/en/iSTAR-Medical-continues-European-expansion-with-first-MINIject-surgeries-in-the-Netherlands.html

GLOBENEWSWIRE
22 Dec 2023

https://www.globenewswire.com//news-release/2023/10/31/2769882/0/en/iSTAR-Medical-conducts-first-MINIject-surgeries-in-Ireland-expanding-commercial-rollout-in-Europe.html

GLOBENEWSWIRE
31 Oct 2023

https://www.globenewswire.com//news-release/2023/09/07/2739005/0/en/iSTAR-Medical-presents-positive-three-year-results-for-MINIject-from-STAR-GLOBAL-trial.html

GLOBENEWSWIRE
07 Sep 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty